Latest filing published 07 Jun 2022 for Zosano Pharma Corp, €54.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christine Matthews: trading record in brief
Christine Matthews (finance chief) discloses dealings in Zosano Pharma Corp to SEC (Form 4). Between 25 June 2020 and 6 June 2022, the trades on record add up to 6 filings.
The open-market record consists of 3 sales worth €2,728, with no purchase. Other entries cover 3 share grants. Since January 2022: no purchases and 2 sales on the market.
On 7 June 2022 came the latest disclosure, an open-market sale for €54 in Zosano Pharma Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christine Matthews
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 82 shares@ US$0.711.4% of flowCommon StockSEC:0000899243-22-021398:0
- 8,116 shares@ US$0.210156.4% of flowCommon StockSEC:0001567619-22-007911:0
- 56,250 shares0Common StockSEC:0001567619-21-018473:0
- 1,709 shares@ US$0.80541.6% of flowCommon StockSEC:0001567619-21-011787:0
4 of 4 declarations
